Anne Dekeyne

3.6k total citations
73 papers, 3.2k citations indexed

About

Anne Dekeyne is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, Anne Dekeyne has authored 73 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cellular and Molecular Neuroscience, 42 papers in Molecular Biology and 13 papers in Social Psychology. Recurrent topics in Anne Dekeyne's work include Neurotransmitter Receptor Influence on Behavior (45 papers), Receptor Mechanisms and Signaling (38 papers) and Neuroscience and Neuropharmacology Research (28 papers). Anne Dekeyne is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (45 papers), Receptor Mechanisms and Signaling (38 papers) and Neuroscience and Neuropharmacology Research (28 papers). Anne Dekeyne collaborates with scholars based in France, United Kingdom and Netherlands. Anne Dekeyne's co-authors include Mark J. Millan, Alain P. Gobert, Mauricette Brocco, Jean‐Michel Rivet, Mark J. Millan, Sylvie Girardon, Adrian Newman‐Tancredi, Florence Loiseau, Jean-Louis Péglion and Mariusz Papp and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Anne Dekeyne

73 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Dekeyne France	33	2.1k	1.3k	528	502	458	73	3.2k
Mauricette Brocco France	34	2.3k 1.1×	1.4k 1.1×	507 1.0×	366 0.7×	374 0.8×	78	3.2k
Sharon Rosenzweig‐Lipson United States	34	1.8k 0.8×	1.2k 0.9×	583 1.1×	409 0.8×	523 1.1×	72	3.4k
Jeffrey Sprouse United States	25	2.1k 1.0×	1.2k 0.9×	424 0.8×	481 1.0×	330 0.7×	53	3.2k
Gary E. Duncan United States	31	1.8k 0.9×	965 0.7×	437 0.8×	720 1.4×	297 0.6×	55	2.9k
Declan N.C. Jones United Kingdom	37	1.7k 0.8×	1.2k 0.9×	459 0.9×	683 1.4×	319 0.7×	64	3.4k
Paola Devoto Italy	33	1.9k 0.9×	863 0.7×	266 0.5×	592 1.2×	492 1.1×	88	3.0k
Lynette C. Daws United States	36	2.4k 1.1×	1.6k 1.2×	383 0.7×	586 1.2×	338 0.7×	106	4.1k
M A Geyer United States	21	2.3k 1.1×	1.2k 0.9×	472 0.9×	979 2.0×	279 0.6×	31	3.7k
Tyra Zetterström United Kingdom	31	3.5k 1.6×	1.6k 1.2×	296 0.6×	585 1.2×	462 1.0×	69	4.8k
Julie G. Hensler United States	31	1.5k 0.7×	744 0.6×	440 0.8×	506 1.0×	299 0.7×	58	2.5k

Countries citing papers authored by Anne Dekeyne

Since Specialization

Citations

This map shows the geographic impact of Anne Dekeyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Dekeyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Dekeyne more than expected).

Fields of papers citing papers by Anne Dekeyne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Dekeyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Dekeyne. The network helps show where Anne Dekeyne may publish in the future.

Co-authorship network of co-authors of Anne Dekeyne

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Dekeyne. A scholar is included among the top collaborators of Anne Dekeyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Dekeyne. Anne Dekeyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fone, K.C.F., David J. Watson, Anne Dekeyne, et al.. (2020). Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management. Molecular Neurobiology. 57(5). 2144–2166. 12 indexed citations

Norman, Trevor R., et al.. (2011). Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: A comparison to melatonin and to the 5-HT2c antagonist, S32006. European Journal of Pharmacology. 674(1). 27–32. 18 indexed citations

Millan, Mark J., Anne Dekeyne, Alain P. Gobert, et al.. (2010). S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: A comparison to aprepitant (MK869) and paroxetine. European Neuropsychopharmacology. 20(9). 599–621. 14 indexed citations

Dekeyne, Anne, Clotilde Mannoury la Cour, Alain P. Gobert, et al.. (2008). S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology. 199(4). 549–568. 100 indexed citations

Millan, Mark J., Per Svenningsson, Charles R. Ashby, et al.. (2007). S33138 [N-[4-[2-[(3 aS,9 bR)-8-Cyano-1,3 a,4,9 b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3 H)-yl)-ethyl]phenylacetamide], a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent. II. A Neurochemical, Electrophysiological and Behavioral Characterization in Vivo. Journal of Pharmacology and Experimental Therapeutics. 324(2). 600–611. 34 indexed citations

Millan, Mark J., Florence Loiseau, Anne Dekeyne, et al.. (2007). S33138 (N-[4-[2-[(3 aS,9 bR)-8-cyano-1,3 a,4,9 b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3 H)-yl)-ethyl]phenyl-acetamide), a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: III. Actions in Models of Therapeutic Activity and Induction of Side Effects. Journal of Pharmacology and Experimental Therapeutics. 324(3). 1212–1226. 69 indexed citations

Millan, Mark J., et al.. (2006). Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors. Psychopharmacology. 191(3). 767–782. 14 indexed citations

Brocco, Mauricette, Anne Dekeyne, Mariusz Papp, & Mark J. Millan. (2006). Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. Behavioural Pharmacology. 17(7). 559–572. 44 indexed citations

Dekeyne, Anne & Mark J. Millan. (2006). Discriminative stimulus properties of the selective and highly potent α2-adrenoceptor agonist, S18616, in rats: Mediation by the α2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin. Neuropharmacology. 51(4). 718–726. 13 indexed citations

10.

Millan, Mark J. & Anne Dekeyne. (2006). Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with α/β-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors. The International Journal of Neuropsychopharmacology. 10(5). 579–93. 9 indexed citations

11.

Millan, Mark J., Mauricette Brocco, Mariusz Papp, et al.. (2004). S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole. Journal of Pharmacology and Experimental Therapeutics. 309(3). 936–950. 48 indexed citations

12.

Dekeyne, Anne, Jean‐Michel Rivet, Alain P. Gobert, & Mark J. Millan. (2001). Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT. Neuropharmacology. 40(7). 899–910. 16 indexed citations

13.

Millan, Mark J., Anne Dekeyne, Mariusz Papp, et al.. (2001). S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: II. Behavioral Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine. Journal of Pharmacology and Experimental Therapeutics. 298(2). 581–591. 104 indexed citations

14.

Millan, Mark J., Mauricette Brocco, Jean‐Michel Rivet, et al.. (2000). S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.. PubMed. 292(1). 54–66. 46 indexed citations

15.

Millan, Mark J., Alain P. Gobert, Jean‐Michel Rivet, et al.. (2000). Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α₂‐adrenergic and serotonin_2C receptors: a comparison with citalopram. European Journal of Neuroscience. 12(3). 1079–1095. 139 indexed citations

16.

Millan, Mark J., Adrian Newman‐Tancredi, Didier Cussac, et al.. (2000). Agonist and antagonist actions of yohimbine as compared to fluparoxan at ?2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse. 35(2). 79–95. 168 indexed citations

17.

Dekeyne, Anne, et al.. (2000). Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats. Psychopharmacology. 153(3). 389–392. 9 indexed citations

18.

Gobert, Alain P., Anne Dekeyne, & Mark J. Millan. (2000). The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572. Neuropharmacology. 39(9). 1608–1616. 35 indexed citations

19.

Marinelli, Michela, Michel Barrot, Hervé Simon, et al.. (1998). Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential. European Journal of Neuroscience. 10(10). 3269–3275. 34 indexed citations

20.

Millan, Mark J., Rudy Schreiber, Anne Dekeyne, et al.. (1998). S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol. Journal of Pharmacology and Experimental Therapeutics. 286(3). 1356–1373. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact